Riskpilot← Back to searchSign inGet full accessFARMAZIE AB
ABIn liquidationOrg 5568908874Hairdressing and other beauty treatment · NACE 9602Est. 20121 employees
Revenue 2022
SEK 105K
-63% vs 2021
EBITDA margin
-23.8%
-120% vs 2021
Equity ratio
75.6%
Financial strength
Net profit 2022
SEK -1K
-101% vs 2021
| Revenue | SEK 105K | -63% |
| EBITDA | SEK -25K | -120% |
| Net profit | SEK -1K | -101% |
| Total assets | SEK 225K | -16% |
| Equity | SEK 170K | -1% |
| Employees | 1 | — |
Legal name
FARMAZIE AB
Org number
5568908874
Legal form
Aktiebolag
NACE code
9602 · Hairdressing and other beauty treatment
Founded
18 april 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-09-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva frisörverksamhet, hud- och nagelvård samt makeup och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 849 | 674 | 314 | 284 | 105 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 23 | −14 | 53 | 124 | −25 |
| Depreciation & amort. | −12 | −12 | −9 | −9 | −6 |
| EBIT | 11 | −26 | 44 | 115 | −31 |
| Net financials | −1 | — | — | — | — |
| Profit before tax | 10 | −27 | 45 | 85 | −1 |
| Tax | −0 | −0 | −3 | −18 | −0 |
| Net profit | 10 | −27 | 42 | 67 | −1 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 314 | 209 | 226 | 269 | 225 |
| Equity | 129 | 103 | 144 | 171 | 170 |
| Long-term debt | 46 | 28 | 17 | 5 | 0 |
| Short-term debt | 138 | 78 | 65 | 63 | 55 |
| Total debt | 184 | 106 | 82 | 68 | 55 |
EBITDA margin
-23.8%
This company
15.8%
Market median
-251% vs market
20182022
Equity ratio
75.6%
This company
38.2%
Market median
+98% vs market
20182022
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20182022
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20182022
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20182022
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-10-01 – 2018-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TR Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2022 – 2023 | |
| Chairman | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FARMAZIE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Rohl Düring | Liquidator | 0 companies |
| Madelen Siripon Gester | Board of Directors | 0 companies |
| Denice Linda Sabine Özel | Chairman | 0 companies |
| Mats Gunnar Gester | Deputy Board Member | 0 companies |